$0.430100
~00.02%
Pre-Market: Jul 19, 4:38 PM EDT
15 minutes delayed
Comments
Loading...
Cadrenal Therapeutics
CVKDNASDAQ
Cadrenal Therapeutics (CVKD) Forecast
NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestCadrenal Therapeutics (NASDAQ:CVKD) Stock Quotes, Forecast and News Summary
Cadrenal Therapeutics Stock (NASDAQ: CVKD) stock price, news, charts, stock research, profile.
| Open | - |
| Close | - |
| Volume / Avg. | 0 / 96.21K |
| Day Range | - - - |
| 52 Wk Range | 0.36 - 2.17 |
| Market Cap | $6.89M |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 40 |
| Short Interest | 0.56% |
| Days to Cover | 1 |
Recent News
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Cadrenal Therapeutics Inc
Sector
Health Care
Industry
Pharmaceuticals
Cadrenal Therapeutics Inc is focused on developing a novel therapy with orphan drug indication, teca...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Cadrenal Therapeutics (CVKD) stock?
You can purchase shares of Cadrenal Therapeutics (NASDAQ:CVKD) through any online brokerage.
Who are Cadrenal Therapeutics (CVKD) competitors?
Other companies in Cadrenal Therapeutics’s space includes: Iterum Therapeutics (NASDAQ:ITRM), Kiora Pharmaceuticals (NASDAQ:KPRX), Universe Pharmaceuticals (NASDAQ:UPC), Sonoma Pharmaceuticals (NASDAQ:SNOA) and Palisade Bio (NASDAQ:PALI).
What is the target price for Cadrenal Therapeutics (CVKD) stock?
There is no analysis for Cadrenal Therapeutics.
What is the forecast for Cadrenal Therapeutics (CVKD) stock?
Cadrenal Therapeutics has a consensus price target of $3.50.
Current stock price for Cadrenal Therapeutics (CVKD)?
The stock price for Cadrenal Therapeutics (NASDAQ: CVKD) is $0.4301 last updated July 19, 2024 at 4:38 PM EDT.
Does Cadrenal Therapeutics (CVKD) pay a dividend?
There are no upcoming dividends for Cadrenal Therapeutics.
When is Cadrenal Therapeutics (NASDAQ:CVKD) reporting earnings?
Cadrenal Therapeutics’s Q2 earnings are confirmed for Monday, August 12, 2024.
Is Cadrenal Therapeutics (CVKD) going to split?
There is no upcoming split for Cadrenal Therapeutics.
What sector and industry does Cadrenal Therapeutics (CVKD) operate in?
Cadrenal Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.